Midazolam infusion

DRUG4 trials

Sponsors

Yonsei University, Yale University, Mostafa Mohamed Atef Mohamed

Conditions

Adolescent DepressionAdolescent SuicideCirculatory System sepsis AnaesthesiaMajor Depressive DisorderSedation

Phase 2

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

TerminatedNCT03889756

Yale UniversityMajor Depressive Disorder

Start: 2019-07-17End: 2023-01-05Updated: 2023-04-24

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

TerminatedNCT04613453

Yale UniversityAdolescent Depression, Adolescent Suicide

Start: 2022-01-21End: 2024-12-03Updated: 2025-08-26

Phase 4

A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit

CompletedNCT01527903

Yonsei UniversitySedation

Start: 2009-09-30End: 2010-06-30Updated: 2016-08-17

Unknown Phase

Effect of Dexmedetomidine vs Midazolam on the microcirculation of septic patients who are mechanically ventilated

Active, not recruitingPACTR202112845314910

Mostafa Mohamed Atef MohamedCirculatory System sepsis Anaesthesia

Start: 2020-02-16Target: 128Updated: 2026-01-27